Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid
In the original case, ruling dated May 17, 2023, the Patent Trial and Appeal Board (PTAB) ruled in favor of Synthego's petitions seeking to invalidate Agilent's US Patents Nos. 10,337,001 (the '001 patent) and 10,900,034 (the '034 patent) in the Inter Partes Review before the PTAB.
The PTAB's original decision invalidated all claims of the Agilent patents, which were directed to guide RNAs having at least one 2'-O-methyl modification ('034 patent) and guide RNAs having certain modifications within 5 nucleotides of their 5' and/or 3' end ('001) patent), as well as methods of using such modified guide RNAs for CRISPR gene editing.
'This critical decision, affirming that Agilent's claims on chemically modified gRNAs are unpatentable, keeps the path clear for broader innovation and advancement in the CRISPR therapeutics market,' said Craig Christianson, CEO of Synthego. 'Synthego will continue our focus on supporting our clients' efforts to enhance human health with curative cell and gene therapies.'
Synthego continues to support innovation in the field of CRISPR-enabled research and therapeutics, this affirmation enables researchers and therapeutic developers to continue to drive successful patient outcomes.
About Synthego
Synthego is a leader in biotechnology, dedicated to delivering best-in-class CRISPR solutions with a mission to accelerate research and development in the pursuit of improved human health. By providing unparalleled access to CRISPR solutions at scale, Synthego enables agility in life science discovery and clinical advancement. With streamlined licensing models and exceptional technical expertise, Synthego empowers researchers and developers to unlock better patient outcomes through innovative CRISPR cell and gene therapies.
View original content to download multimedia: https://www.prnewswire.com/news-releases/synthego-prevails-in-patent-appeal-confirming-agilent-crispr-patents-are-invalid-302479683.html
SOURCE Synthego
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Quadient Announces Supplier Agreement with Vizient, Enhancing Access to the U.S. Healthcare Market
Quadient Announces Supplier Agreement with Vizient, Enhancing Access to the U.S. Healthcare Market Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, has entered into a supplier agreement with Vizient, the largest provider-driven healthcare performance improvement company in the U.S. Vizient's diverse client base includes some of the country's most prestigious hospitals and integrated health delivery networks. The agreement enhances opportunities for Quadient to serve healthcare providers across the continuum of care, offering contracted pricing for a wide range of the company's digital software, mail and automated locker solutions. Vizient provides network-powered insights into the critical areas of clinical, operational and spend management performance and empowers clients to deliver exceptional, cost-effective care. Serving more than 65% of U.S. acute care providers and more than 35% of the non-acute market, Vizient's contract portfolio represents $140 billion in annual purchasing volume. Through the new contract, healthcare providers have greater access to Quadient's cutting-edge solutions designed to enhance digital patient interactions, optimize the sending and receiving of mail and packages, improve operational efficiency, increase document security and ensure regulatory compliance. 'We are thrilled to be awarded a contract from Vizient to help healthcare organizations improve performance through more streamlined and automated workflows, leading to better patient and staff experiences' said Geoffrey Godet, CEO at Quadient. 'Our strategic approach to supply chain and procurement in the mailing and communications space is rooted in a comprehensive, assessment-based process that identifies key assets and opportunities to drive efficiency and transformation for healthcare providers. We are excited to support Vizient clients with innovative, results-driven solutions that enhance operational performance and elevate the overall healthcare experience.' For more information about Quadient's solutions and contract with Vizient, visit and About Quadient®Quadient is a global automation platform powering secure and sustainable business connections through digital and physical channels. Quadient supports businesses of all sizes in their digital transformation and growth journey, unlocking operational efficiency and creating meaningful customer experiences. Listed in compartment B of Euronext Paris (QDT) and part of the CAC® Mid & Small and EnterNext® Tech 40 indices, Quadient shares are eligible for PEA-PME investing. For more information about Quadient, visit Media ContactsJoe Scolaro, QuadientGlobal Press Relations Manager+1 203-301-3673jscolaro@ Kiley Ribordy, Walker SandsSenior PR Directorquadientpr@ Attachment PR Quadient Vizient Contract_EN_finalError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Wall Street Journal
18 minutes ago
- Wall Street Journal
Treasury Yields Mixed Ahead of Inflation Report
1535 ET – Treasury yields are mixed and little changed from Friday, as markets brace for an uptick in inflation tomorrow. June CPI is forecast, in a WSJ survey, to accelerate to 2.7% from May's 2.4%, with the core reading rising to 3% from 2.8%. Trump's new tariff announcements keep uncertainty elevated, as the threatens Russia with 100% levies if it doesn't stop hostilities in Ukraine. That follows the weekend's announcement of 30% tariffs on the EU and Mexico. The 10-year yield gains 0.003 percentage point to 4.426% and the two-year declines 0.017p.p. to 3.896%. ( @ptrevisani) 1425 ET – The dollar strengthens, while Treasury yields pare gains, as Trump floats 100% tariffs on Russia. The president says the U.S. will impose tariffs if Russia doesn't agree to halt hostilities in Ukraine in 50 days. He said the levies would be 'at about 100%.' The news broke at around noon ET. Since then, the WSJ Dollar Index has increased its gains. It's now up 0.2% as the greenback strengthens 0.4% versus the yen and 0.1% against the euro. Treasury yields give back some of their morning increases and are around flat compared to Friday. The 10-year is at 4.424% and the two-year at 3.896%. ( @ptrevisani)
Yahoo
21 minutes ago
- Yahoo
ASML Walks Back 2026 Growth Forecast as Tariffs Muddy Outlook
(Bloomberg) -- ASML Holding NV Chief Executive Officer Christophe Fouquet walked back the company's growth forecast for next year due to trade disputes, even though second-quarter orders beat estimates. The Dutch Intersection Is Coming to Save Your Life Advocates Fear US Agents Are Using 'Wellness Checks' on Children as a Prelude to Arrests LA Homelessness Drops for Second Year Manhattan, Chicago Murder Rates Drop in 2025, Officials Say 'Looking at 2026, we see that our AI customers' fundamentals remain strong,' Fouquet said in a statement on ASML's quarterly results Wednesday. 'At the same time, we continue to see increasing uncertainty driven by macro-economic and geopolitical developments. Therefore, while we still prepare for growth in 2026, we cannot confirm it at this stage.' The Dutch company reported bookings of €5.5 billion ($6.4 billion) in the second quarter, it said in the statement. That compares with an average estimate of €4.8 billion by analysts in data compiled by Bloomberg. Fouquet highlighted the threat of tariffs for new systems and parts sent to the US, as well the threat of other countries reacting with reciprocal measures. Tariffs could also negatively hit ASML's gross margin, he said. Semiconductors are currently exempt from US tariffs but there's uncertainty over how chip-making equipment will be affected. The Trump administration's chaotic rollout has roiled markets and made planning major spending difficult. ASML forecast third-quarter net sales between €7.4 billion and €7.9 billion, missing estimates. It expects 15% revenue growth for the year. ASML, which counts Taiwan Semiconductor Manufacturing Co. and Intel Corp. among its customers, is poised to benefit from hundreds of billions of dollars of investment pouring into AI data centers because it is the only company that makes extreme ultraviolet lithography machines. That technology is needed to produce Nvidia Corp.'s most cutting-edge chips, which are the backbone of much of the planned AI infrastructure. Signs of a thaw between the Trump administration and Beijing could bode well for ASML. On Tuesday, Nvidia and Advanced Micro Devices Inc. said they would restart sales of some chips to China that had previously been blocked, after gaining assurances from Washington that the shipments would be approved. ASML faces a number of limits on its sales to China, which was the company's second-biggest market in the first quarter. It has never been able to sell its most-advanced EUV machines to China because of US-led restrictions. Last year, the Dutch government also blocked immersion deep ultraviolet lithography systems to the country after pressure from the US. There's no suggestion so far that ASML machines would see a relaxation of the rules, but it would benefit from higher demand from its customers selling more to China. Belt tightening further along the supply chain has hit ASML, too. Intel is slashing expenses in a restructuring that includes delays to planned factories in Germany and Poland. What Bloomberg Intelligence Says ASML's 2Q results and 3Q outlook, released July 16, imply its business environment hasn't materially changed despite US tariffs on imports of chip-making tools and limits on sales to China. Its 2Q order bookings of €5.5 billion suggest the company could sustain strong system sales in 3Q and 4Q. As ASML has maintained guidance of 15% sales growth for 2025, it could report strong sequential growth in 4Q sales. — BI analysts Masahiro Wakasugi and Takumi Okano Samsung Electronics Co. reported its first fall in profit since 2023 last week as it lost market share in the AI market, although some analysts expect the company to hit bottom this summer. ASML's shares rose 2.7% to €706.10 in Amsterdam on Tuesday. They have fallen 28% in the last year. Forget DOGE. Musk Is Suddenly All In on AI How Hims Became the King of Knockoff Weight-Loss Drugs Thailand's Changing Cannabis Rules Leave Farmers in a Tough Spot How Starbucks Is Engineering a Turnaround With Warm Vibes and Cold Foams The New Third Rail in Silicon Valley: Investing in Chinese AI ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
